|
RBBP4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74719999999073E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.063290E-03 |
| Normal-vs-Stage2 |
8.277400E-03 |
| Normal-vs-Stage3 |
1.76730000001069E-06 |
| Normal-vs-Stage4 |
7.231900E-04 |
| Stage1-vs-Stage2 |
5.865000E-01 |
| Stage1-vs-Stage3 |
1.692440E-02 |
| Stage1-vs-Stage4 |
3.595400E-01 |
| Stage2-vs-Stage3 |
3.468600E-01 |
| Stage2-vs-Stage4 |
9.168400E-01 |
| Stage3-vs-Stage4 |
3.183000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.569800E-04 |
| Normal-vs-AfricanAmerican |
4.94880003643061E-09 |
| Normal-vs-Asian |
7.276600E-01 |
| Caucasian-vs-AfricanAmerican |
3.022800E-04 |
| Caucasian-vs-Asian |
3.513800E-01 |
| AfricanAmerican-vs-Asian |
2.432300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.03079999997014E-06 |
| Normal-vs-Female |
1.778140E-03 |
| Male-vs-Female |
1.655010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.000020E-03 |
| Normal-vs-Age(41-60Yrs) |
3.592800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.355700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.71700000000308E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.037200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.525200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.773400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.438000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.565900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.291600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.774400E-01 |
| Normal-vs-Grade 2 |
2.711600E-02 |
| Normal-vs-Grade 3 |
2.15100000000579E-06 |
| Normal-vs-Grade 4 |
1.89139999995369E-07 |
| Grade 1-vs-Grade 2 |
4.817000E-01 |
| Grade 1-vs-Grade 3 |
5.734100E-02 |
| Grade 1-vs-Grade 4 |
1.252060E-02 |
| Grade 2-vs-Grade 3 |
1.042290E-03 |
| Grade 2-vs-Grade 4 |
1.588460E-04 |
| Grade 3-vs-Grade 4 |
1.430770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.931170E-01 |
| Normal-vs-ccB subtype |
6.59529999946784E-07 |
| ccA subtype-vs-ccB subtype |
1.59929999998809E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.219280E-04 |
| Normal-vs-N1 |
2.733400E-01 |
| N0-vs-N1 |
7.977200E-01 |
|
|
